TMS Provider Spotlight – a Q&A with Khaled Bowarshi MD
We spoke with Dr Bowarshi from his Florida TMS Clinic. Dr Bowarshi is board-certified in both Internal Medicine and Psychiatry.
Magstim Group Appoints Luciën van Os as Chief Technology Officer for Global Minimally-Invasive Neurotechnology Portfolio
Van Os To Oversee Product & Technology Development For Magstim TMS, Electrical Geodesics (EGI) EEG, Technomed Neurophysiology and Neurosign Intraoperative Nerve Monitoring Brands
Magstim Welcomes EGI
Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio High-density EEG [...]
Rhythm and Acceleration in TMS – Magstim Academy June 11th
Magstim Academy Lecture Series – Rhythm and Acceleration - recent advances in TMS treatment for mood disorders. Mark George, MD, Nolan Williams, MD and Martijn Arns, PhD will present on their recently published and on-going TMS studies.
Magstim Academy Lecture Series
Magstim Academy Lecture Series – this live series will begin on May 12th and cover cutting-edge magnetic stimulation research.
Message from our CEO
My team would like to thank all the TMS clinicians [...]
First clinical TMS navigation system receives 510k clearance
Magstim® TMS has launched the very first Transcranial Magnetic Stimulation navigation system specifically developed for the clinical market.
Magstim TMS receives FDA clearance for 3- minute theta burst treatment
Magstim has received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for Major Depressive Disorder with its Horizon® TMS Therapy systems.
Inside Magstim
Take a look inside Magstim. At Magstim, we believe in [...]
NHS clinical trial could pave the way for new depression treatment
How we treat depression in the future may be set to change as the NHS begins an unprecedented two year study using transcranial magnetic stimulation (TMS).
